, Tracking Stock Market Picks
Enter Symbol:
Atricure, Inc. (ATRC) [hlAlert]

up 121.87 %

Atricure, Inc. (ATRC) rated Outperform by BMO Capital Markets

Posted on: Wednesday,  Apr 23, 2008  9:25 AM ET by BMO Capital Markets

BMO Capital Markets rated Outperform Atricure, Inc. (NASDAQ: ATRC) on 04/23/2008, when the stock price was $11.84. Since
then, Atricure, Inc. has gained 121.88% as of 01/06/2016's recent price of $26.27.
If you would have followed this BMO Capital Markets's recommendation on ATRC, you would have gained 121.87% of your investment in 2814 days.

AtriCure, Inc. is a medical device company that develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. The Company's primary product line, which accounts for a majority of its revenues, is the AtriCure Isolator system. AtriCure's Isolator system consists primarily of a compact power generator known as an ablation and sensing unit (ASU), a switchbox unit (ASB), which allows physicians to toggle between multiple products and multiple configurations of its Isolator clamps, including its Isolator Synergy clamps. AtriCure also sells a multifunctional bipolar pen, or multifunctional pen, which is often used by physicians in combination with its Isolator system to ablate cardiac tissue and for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias. In 2008, The Company received FDA approval for its EXCLUDE clinical trial.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/23/2008 9:25 AM Buy
as of 12/24/2008
1 Week down  -22.46 %
1 Month down  -16.40 %
3 Months down  -41.20 %
1 YTD down  -51.80 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy